TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
11,758,102
Share change
-819,790
Total reported value
$5,761,410
Price per share
$0.49
Number of holders
20
Value change
-$394,949
Number of buys
5
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q1 2023

As of 31 Mar 2023, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,758,102 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, GREENLIGHT CAPITAL INC, ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MERCER GLOBAL ADVISORS INC /ADV, and MORGAN STANLEY. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.